MedPath

PF-05089771

Generic Name
PF-05089771
Drug Type
Small Molecule
Chemical Formula
C18H12Cl2FN5O3S2
CAS Number
1235403-62-9
Unique Ingredient Identifier
25U4N985O2

Overview

PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2023/07/07
Early Phase 1
Completed
2015/01/29
Phase 1
Completed
2014/08/13
Phase 2
Completed
2013/09/04
Phase 1
Completed
2013/05/16
Phase 1
Completed
2013/01/21
Phase 1
Completed
2013/01/16
Phase 2
Completed
2012/09/21
Phase 1
Completed
2012/03/27
Phase 1
Completed
2012/02/09
Phase 1
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.